Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SAFEstart for Feeding Intolerance in NICU
NCT00331201Phase 2Completed
- Sponsor
- Intermountain Health
- Start
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of SAFEstart in feeding intolerance, sponsored by Intermountain Health. Started Jul 2005; status: completed.
02
Drugs
SAFEstart
03
Conditions
feeding intolerance
Beyond the preview
Go deeper on NCT00331201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00331201.